enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Big Pharma: Why the drug industry faces a 3-front battle with ...

    www.aol.com/finance/big-pharma-why-drug-industry...

    The collapse of the deal is the latest example of how the pharmaceutical industry is battling the US government on a number of fronts, including the White House's move to license drugs that were ...

  3. Pharma Stock Roundup: Regulatory Updates in Focus at ... - AOL

    www.aol.com/news/pharma-stock-roundup-regulatory...

    For premium support please call: 800-290-4726 more ways to reach us

  4. Pharma Stock Roundup: J&J's Mixed Q1 Results, FDA Updates for ...

    www.aol.com/news/pharma-stock-roundup-j-js...

    For premium support please call: 800-290-4726 more ways to reach us

  5. Scrip World Pharmaceutical News - Wikipedia

    en.wikipedia.org/wiki/Scrip_World_Pharmaceutical...

    It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials. In 2022, Informa sold its Pharma Intelligence division, including Scrip, to Warburg Pincus. [4] The business was renamed Citeline.

  6. Texas Pharmacy Association - Wikipedia

    en.wikipedia.org/wiki/Texas_Pharmacy_Association

    The Texas Pharmacy Association was formed as the Texas Pharmaceutical Association (TPA) in the May 1879 in the back of a pharmacy in Dallas, Texas.The name was updated in 1994 to incorporate the idea of pharmacy as a multidisciplinary field that combines a tangible drug product with an intangible cognitive service, which has been developed to be known as Medication Therapy Management.

  7. Pharma Stock Roundup: FDA Panel's Nod to PFE/BNTX ... - AOL

    www.aol.com/news/pharma-stock-roundup-fda-panels...

    An FDA panel recommends granting approval for emergency use of Pfizer's (PFE) COVID-19 vaccine. Glaxo (GSK)/Sanofi (SNY) COVID-19 vaccine plan delays.

  8. Cassava Sciences - Wikipedia

    en.wikipedia.org/wiki/Cassava_Sciences

    Cassava Sciences was founded by Remi Barbier in May 1998 as Pain Therapeutics, [3] [4] focusing on opioids and chronic pain. [5] Barbier first heard of the research led by Stanley M. Crain at the Albert Einstein College of Medicine in New York City around 1993. [5]

  9. Pharma Stock Roundup: PFE, SNY, ABBV's Pipeline Updates ... - AOL

    www.aol.com/news/pharma-stock-roundup-pfe-sny...

    For premium support please call: 800-290-4726 more ways to reach us